In people at the lower end of the older-aged spectrum (aged 50 to 60 years), higher levels of IGF-1 were associated with lower odds of hearing impairment and most particularly in participants free of hearing impairment at baseline, where a moderately high effect size was found. The gene discussed is IGF1; the disease is hearing loss disorder.